Revel Pharmaceuticals
About:
Revel Pharmaceuticals develops therapeutics for multiple diseases of aging including osteoarthritis, kidney, and complications of diabetes.
Website: https://www.revelpharmaceuticals.com/
Top Investors: Starbloom Capital, KIZOO Technology Capital, Tubus
Description:
Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes. It is commercializing therapeutic enzymes to degrade age-associated molecule damage.
Total Funding Amount:
$8.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2019-01-01
Founders:
AARON CRAVENS, Nicholas DeLateur
Number of Employees:
1-10
Last Funding Date:
2022-03-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai